Toshitaka Sugi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Toshitaka Sugi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Tsunehisa Makino
Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan
5 shared publicationsK Toyoshima
3 shared publicationsR Iizuka
3 shared publicationsS Nozawa
3 shared publicationsT Makino
Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo
3 shared publicationsAkifumi Inomo
Department of Obstetrics and Gynecology, Specialized Clinical Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan
2 shared publications
Latest Publications
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (02) , 316-323
The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses
Recently, numerous studies have suggested an association between factor XII (FXII) deficiency and recurrent pregnancy losses, and between autoantibodies to FXII and recurrent pregnancy losses. Autoantibodies to FXII rather than FXII deficiency may be a risk factor for recurrent pregnancy losses. To know the pathogenesis of autoantibodies to FXII, epitope mapping study was done. Seventeen anti-FXII antibody positive recurrent pregnancy loss patients were chosen for this study. We used synthetic peptides in inhibition and direct binding studies to identify the antigenic binding site of autoantibodies to FXII. Among plasmas from 17 recurrent pregnancy loss patients who were positive for autoantibodies to FXII, 13 patients (76.5%) recognized amino acids 1–30, the amino-terminal heavy chain region that is known as factor XII binding site to platelet glycoprotein Ibα. * Both authors contributed equally to this report.
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (02) , 316-323
The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses
Recently, numerous studies have suggested an association between factor XII (FXII) deficiency and recurrent pregnancy losses, and between autoantibodies to FXII and recurrent pregnancy losses. Autoantibodies to FXII rather than FXII deficiency may be a risk factor for recurrent pregnancy losses. To know the pathogenesis of autoantibodies to FXII, epitope mapping study was done. Seventeen anti-FXII antibody positive recurrent pregnancy loss patients were chosen for this study. We used synthetic peptides in inhibition and direct binding studies to identify the antigenic binding site of autoantibodies to FXII. Among plasmas from 17 recurrent pregnancy loss patients who were positive for autoantibodies to FXII, 13 patients (76.5%) recognized amino acids 1–30, the amino-terminal heavy chain region that is known as factor XII binding site to platelet glycoprotein Ibα. * Both authors contributed equally to this report.
- 7 February 2007
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 57 (3) , 232
IgG‐antiphospholipid antibodies in follicular fluid of IVF‐ET patients are related to low fertilization rate of their oocytes
- 7 February 2007
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 57 (3) , 232
IgG‐antiphospholipid antibodies in follicular fluid of IVF‐ET patients are related to low fertilization rate of their oocytes
- 1 August 2005
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 6 (5) , 551-557
Factor XII, Kininogen and Plasma Prekallikrein in Abnormal Pregnancies
Factor XII, plasma prekallikrein and high molecular weight kininogen were first identified as coagulation proteins in the intrinsic pathway because patients deficient in these proteins had marked prolongation of in vitro surfaceactivated coagulation time. However, deficiencies of these proteins are not associated with clinical bleeding. Paradoxically, studies suggest that these proteins have anticoagulant and profibrinolytic activities. In fact, association between deficiencies of these proteins and thrombosis has been reported. Also, deficiencies of these proteins, auto-antibodies to these proteins and anti-phospholipid antibodies are frequent hemostatis-related abnormalities found in unexplained recurrent aborters. Recently, evidence has accumulated for the presence of the kallikrein-kininogen-kinin system in the fetoplacental unit. Since contact proteins or kallikrein-kininogen-kinin system may play an important role in pregnancy especially in the fetoplacental unit, deficiencies of these proteins and/or auto-antibodies to these proteins may be associated with pregnancy losses. These possibilities will be reviewed, the functions of the individual components will be summarized, and their role in blood coagulation and pregnancy discussed.
- 1 August 2005
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 6 (5) , 551-557
Factor XII, Kininogen and Plasma Prekallikrein in Abnormal Pregnancies
Factor XII, plasma prekallikrein and high molecular weight kininogen were first identified as coagulation proteins in the intrinsic pathway because patients deficient in these proteins had marked prolongation of in vitro surfaceactivated coagulation time. However, deficiencies of these proteins are not associated with clinical bleeding. Paradoxically, studies suggest that these proteins have anticoagulant and profibrinolytic activities. In fact, association between deficiencies of these proteins and thrombosis has been reported. Also, deficiencies of these proteins, auto-antibodies to these proteins and anti-phospholipid antibodies are frequent hemostatis-related abnormalities found in unexplained recurrent aborters. Recently, evidence has accumulated for the presence of the kallikrein-kininogen-kinin system in the fetoplacental unit. Since contact proteins or kallikrein-kininogen-kinin system may play an important role in pregnancy especially in the fetoplacental unit, deficiencies of these proteins and/or auto-antibodies to these proteins may be associated with pregnancy losses. These possibilities will be reviewed, the functions of the individual components will be summarized, and their role in blood coagulation and pregnancy discussed.
- 7 July 2004
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 30 (4) , 326-332
Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid‐to‐late pregnancy loss*
Aim: Associations have been reported between antiphospholipid antibodies (aPL), mainly anticardiolipin antibodies (aCL) and/or the lupus anticoagulant, and recurrent pregnancy losses (RPL). However, relatively few studies describing antiphosphatidylethanolamine antibodies (aPE) have been reported. We describe the prevalence of aPL to both cardiolipin and phosphatidylethanolamine in patients with RPL.Methods: Patients with recurrent early pregnancy losses (n = 145) and mid‐to‐late pregnancy loss(es) (n = 26) were screened for aPE and aCL.Results: In patients with recurrent early pregnancy losses, prevalence of immunoglobulin G (IgG) aPE (17.9%, P = 0.001) and immunoglobulin M (IgM) aPE (12.4%, P = 0.01) was significantly higher than in the control group. In patients with mid‐to‐late pregnancy loss(es), prevalence of IgM aPE (19.2%, P = 0.008) and IgG aCL (23.1%, P = 0.02) was significantly higher than in the control group.Conclusion: Our data suggest that aPE may be a risk factor in patients with mid‐to‐late pregnancy loss(es) as well as recurrent early pregnancy losses.
- 7 July 2004
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 30 (4) , 326-332
Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid‐to‐late pregnancy loss*
Aim: Associations have been reported between antiphospholipid antibodies (aPL), mainly anticardiolipin antibodies (aCL) and/or the lupus anticoagulant, and recurrent pregnancy losses (RPL). However, relatively few studies describing antiphosphatidylethanolamine antibodies (aPE) have been reported. We describe the prevalence of aPL to both cardiolipin and phosphatidylethanolamine in patients with RPL.Methods: Patients with recurrent early pregnancy losses (n = 145) and mid‐to‐late pregnancy loss(es) (n = 26) were screened for aPE and aCL.Results: In patients with recurrent early pregnancy losses, prevalence of immunoglobulin G (IgG) aPE (17.9%, P = 0.001) and immunoglobulin M (IgM) aPE (12.4%, P = 0.01) was significantly higher than in the control group. In patients with mid‐to‐late pregnancy loss(es), prevalence of IgM aPE (19.2%, P = 0.008) and IgG aCL (23.1%, P = 0.02) was significantly higher than in the control group.Conclusion: Our data suggest that aPE may be a risk factor in patients with mid‐to‐late pregnancy loss(es) as well as recurrent early pregnancy losses.
- Open Access
- 1 July 2003
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 18 (7) , 1553-1554
Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population
- 1 July 2003
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 18 (7) , 1553-1554
Open AccessAntiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population
- 25 April 2002
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 47 (5) , 283-288
Antiphospholipid Antibodies and Kininogens in Pathologic Pregnancies: A Review
PROBLEM: Recently, evidence has accumulated for the presence of the kallikrein–kinin system or plasma contact system in the fetoplacental unit. The Kallikrein–kinin system or plasma contact system consists of three essential plasma proteins. These are coagulation factor XII, prekallikrein and high molecular weight kininogen. Deficiencies of these proteins and antiphospholipid antibodies are frequent hemostasis‐related abnormalities found in unexplained recurrent aborters.METHOD OF STUDY: Review of existing data.RESULTS: Reports of antiphosphatidylethanolamine antibodies (aPE) with similar or identical pathogenic associations as those described for anticardiolipin antibodies (aCL) are found in the literature. We showed a strong association between recurrent pregnancy losses and aPE, the latter of which recognizes kininogens, and kininogen‐binding proteins, factor XI and prekallikrein. The reports of aPE are reviewed, the function of the kininogens are summarized, and their role in pregnancy is discussed.CONCLUSIONS: Because kallikrein–kinin system may play an important role in pregnancy especially in fetoplacental unit, disruption of this system may be a risk factor for early gestational losses.
- 25 April 2002
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 47 (5) , 283-288
Antiphospholipid Antibodies and Kininogens in Pathologic Pregnancies: A Review
PROBLEM: Recently, evidence has accumulated for the presence of the kallikrein–kinin system or plasma contact system in the fetoplacental unit. The Kallikrein–kinin system or plasma contact system consists of three essential plasma proteins. These are coagulation factor XII, prekallikrein and high molecular weight kininogen. Deficiencies of these proteins and antiphospholipid antibodies are frequent hemostasis‐related abnormalities found in unexplained recurrent aborters.METHOD OF STUDY: Review of existing data.RESULTS: Reports of antiphosphatidylethanolamine antibodies (aPE) with similar or identical pathogenic associations as those described for anticardiolipin antibodies (aCL) are found in the literature. We showed a strong association between recurrent pregnancy losses and aPE, the latter of which recognizes kininogens, and kininogen‐binding proteins, factor XI and prekallikrein. The reports of aPE are reviewed, the function of the kininogens are summarized, and their role in pregnancy is discussed.CONCLUSIONS: Because kallikrein–kinin system may play an important role in pregnancy especially in fetoplacental unit, disruption of this system may be a risk factor for early gestational losses.
- 1 January 2002
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 53 (1-2) , 269-277
Autoantibodies to contact proteins in patients with recurrent pregnancy losses
- 1 January 2002
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 53 (1-2) , 269-277
Autoantibodies to contact proteins in patients with recurrent pregnancy losses
- 1 November 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 17 (3) , 207-214
Certain Autoantibodies to Phosphatidylethanolamine (aPE) Recognize Factor XI and Prekallikrein Independently or in Addition to the Kininogens
- 1 November 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 17 (3) , 207-214
Certain Autoantibodies to Phosphatidylethanolamine (aPE) Recognize Factor XI and Prekallikrein Independently or in Addition to the Kininogens
- 1 July 2000
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 47 (2) , 169-184
Plasma contact system, kallikrein–kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy
- 1 July 2000
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 47 (2) , 169-184
Plasma contact system, kallikrein–kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy
- 1 June 1999
- Published by Elsevier in Fertility and Sterility
- Vol. 71 (6) , 1060-1065
Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses
- 1 June 1999
- Published by Elsevier in Fertility and Sterility
- Vol. 71 (6) , 1060-1065
Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses